MaaT Pharma SA (EPA:MAAT)

MaaT Pharma Revenue

In the year 2025, MaaT Pharma had annual revenue of 4.52M EUR with 40.67% growth. MaaT Pharma had revenue of 2.10M in the half year ending December 31, 2025, with 146.71% growth.

• Revenue: 4.52M
• Revenue Growth: +40.67%
• P/S Ratio: 30.20
• Revenue / Employee: 80.79K
• Employees: 59
• Market Cap: 136.62M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.52M	1.31M	40.67%
Dec 31, 2024	3.22M	988.00K	44.34%
Dec 31, 2023	2.23M	798.00K	55.80%
Dec 31, 2022	1.43M	458.00K	47.12%
Dec 31, 2021	972.00K	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 11, 2026

Data Sources Report a data error